# Stereotactic Radiotherapy and Image-guided Intensity Modulated Radiotherapy for Spinal Metastatic Tumors

> **NCT03963713** · NA · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Radiotherapy
- Spine Metastases
- Radiosurgery

## Interventions

- **RADIATION:** Stereotactic radiotherapy
- **RADIATION:** Conventionally-fractionated image- guided Intensity modulated radiotherapy

## Key facts

- **NCT ID:** NCT03963713
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-10
- **Primary completion:** 2021-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-07-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963713, "Stereotactic Radiotherapy and Image-guided Intensity Modulated Radiotherapy for Spinal Metastatic Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03963713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*